Annual Short Term Debt
$652.00 K
-$13.24 M-95.31%
31 December 2023
Summary:
Mereo BioPharma annual short term debt is currently $652.00 thousand, with the most recent change of -$13.24 million (-95.31%) on 31 December 2023. During the last 3 years, it has fallen by -$214.80 thousand (-24.78%). MREO annual short term debt is now -97.19% below its all-time high of $23.24 million, reached on 31 December 2019.MREO Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$6.29 M
+$677.00 K+12.07%
30 September 2024
Summary:
Mereo BioPharma quarterly short term debt is currently $6.29 million, with the most recent change of +$677.00 thousand (+12.07%) on 30 September 2024. MREO quarterly short term debt is now -72.95% below its all-time high of $23.24 million, reached on 31 December 2019.MREO Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MREO Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -95.3% | - |
| 3 y3 years | -24.8% | +527.5% |
| 5 y5 years | -92.5% | -38.1% |
MREO Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -95.3% | at low | -68.7% | +864.3% |
| 5 y | 5 years | -97.2% | at low | -73.0% | +864.3% |
| alltime | all time | -97.2% | at low | -73.0% | +864.3% |
Mereo BioPharma Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.29 M(+12.1%) |
| June 2024 | - | $5.61 M(+6.0%) |
| Mar 2024 | - | $5.29 M(+711.7%) |
| Dec 2023 | $652.00 K(-95.3%) | $652.00 K(-88.9%) |
| June 2023 | - | $5.90 M(-57.6%) |
| Dec 2022 | $13.89 M(+1554.6%) | $13.89 M(-30.7%) |
| June 2022 | - | $20.05 M(+2288.5%) |
| Dec 2021 | $839.50 K | $839.50 K(-16.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $1.00 M(+15.6%) |
| Dec 2020 | $866.80 K(-96.3%) | $866.80 K(-95.0%) |
| June 2020 | - | $17.41 M(-25.1%) |
| Dec 2019 | $23.24 M(+167.8%) | $23.24 M(+128.9%) |
| June 2019 | - | $10.15 M(+17.0%) |
| Dec 2018 | $8.68 M(+231.0%) | $8.68 M(+17.6%) |
| June 2018 | - | $7.38 M(+181.5%) |
| Dec 2017 | $2.62 M | $2.62 M |
FAQ
- What is Mereo BioPharma annual short term debt?
- What is the all time high annual short term debt for Mereo BioPharma?
- What is Mereo BioPharma annual short term debt year-on-year change?
- What is Mereo BioPharma quarterly short term debt?
- What is the all time high quarterly short term debt for Mereo BioPharma?
What is Mereo BioPharma annual short term debt?
The current annual short term debt of MREO is $652.00 K
What is the all time high annual short term debt for Mereo BioPharma?
Mereo BioPharma all-time high annual short term debt is $23.24 M
What is Mereo BioPharma annual short term debt year-on-year change?
Over the past year, MREO annual short term debt has changed by -$13.24 M (-95.31%)
What is Mereo BioPharma quarterly short term debt?
The current quarterly short term debt of MREO is $6.29 M
What is the all time high quarterly short term debt for Mereo BioPharma?
Mereo BioPharma all-time high quarterly short term debt is $23.24 M